Treatment Overview
Submacular Hemorrhage Removal Surgery in Korea is a specialized microsurgical procedure designed to treat bleeding beneath the macula, often caused by wet age-related macular degeneration (AMD), trauma, or polypoidal choroidal vasculopathy (PCV). Submacular hemorrhages can rapidly damage photoreceptors and lead to severe vision loss if not promptly treated.
The procedure involves pars plana vitrectomy (PPV) to access the submacular space, followed by displacement or removal of the hemorrhage using techniques such as subretinal injection of tissue plasminogen activator (tPA), aspiration, or gas tamponade to reposition the blood. Korean retina specialists employ microincision vitrectomy systems, intraoperative OCT, and AI-assisted surgical planning to maximize safety and visual outcomes.
Korea’s advanced submacular hemorrhage removal programs integrate:
- 25G/27G microincision vitrectomy for minimal trauma and faster recovery
- Subretinal tPA injection for clot liquefaction
- Gentle aspiration or pneumatic displacement of blood
- Gas tamponade to stabilize macular anatomy
- Intraoperative OCT for precise subretinal monitoring
- Rapid outpatient or short-stay surgical protocols
- Combination with anti-VEGF therapy when needed
This modern approach helps preserve central vision, reduce photoreceptor damage, and improve retinal anatomy.
Purpose & Benefits
Purpose
- Remove or displace submacular hemorrhage
- Protect photoreceptors from prolonged blood toxicity
- Restore macular anatomy
- Improve visual outcomes after acute bleeding
- Serve as a platform for adjunctive anti-VEGF therapy
Benefits
- Minimally invasive microincision surgery
- Rapid clearance or displacement of submacular blood
- Improved central vision and reduced distortion
- Precise intraoperative OCT guidance enhances safety
- Can be combined with gas tamponade and anti-VEGF therapy
Ideal Candidates
Submacular Hemorrhage Removal Surgery in Korea is ideal for:
- Patients with acute or recent submacular hemorrhage
- Individuals with vision loss due to wet AMD or PCV
- Eyes with macular hemorrhage unresponsive to injections alone
- Patients requiring prompt intervention to prevent permanent photoreceptor damage
- Cases suitable for combined anti-VEGF therapy and vitrectomy
Possible Risks & Complications
Common/Moderate Risks
- Temporary blurred vision
- Mild postoperative inflammation
- Increased intraocular pressure
- Minor retinal edema
Rare/Serious Risks
- Retinal tear or detachment
- Recurrent submacular hemorrhage
- Endophthalmitis (infection)
- Persistent macular edema or scarring
- Vision loss in severe or complicated cases
Korean specialists minimize risks through:
- Microincision vitrectomy (25G/27G) for minimal trauma
- Intraoperative OCT guidance for precise hemorrhage removal
- Controlled subretinal tPA injection and aspiration
- Meticulous postoperative monitoring with OCT and fundus imaging
Related Diagnostic & Treatment Techniques
- Pars Plana Vitrectomy (PPV) – Core surgical approach
- Subretinal tPA Injection – Liquefies clot for removal
- Gas Tamponade – Stabilizes macula post-surgery
- Pneumatic Displacement – Moves submacular blood away from the fovea
- Anti-VEGF Therapy – Treats underlying neovascularization
- Intraoperative OCT – Real-time subretinal visualization
Treatment Process in Korea
Step 1 – Preoperative Assessment
- OCT and fundus imaging to map submacular hemorrhage
- Visual acuity testing and retinal thickness assessment
- Determination of tPA dose and surgical strategy
Step 2 – Surgical Planning
- Select vitrectomy gauge (25G/27G)
- Plan subretinal tPA injection and aspiration technique
- Decide on gas tamponade type (SF6, C3F8)
- Evaluate need for concurrent anti-VEGF therapy
Step 3 – Submacular Hemorrhage Removal Surgery
- Local or general anesthesia
- Microincision vitrectomy to clear vitreous hemorrhage
- Subretinal tPA injection to liquefy clot
- Gentle aspiration or pneumatic displacement of blood
- Gas tamponade to maintain macular positioning
- Optional anti-VEGF injection at the conclusion
Step 4 – Postoperative Evaluation
- OCT imaging to confirm blood displacement
- Monitor visual acuity and intraocular pressure
- Prescribe anti-inflammatory and antibiotic drops
Step 5 – Follow-Up & Maintenance
- Routine OCT and fundus examinations
- Additional anti-VEGF therapy if required
- Intervention only if recurrent hemorrhage or complications occur
Duration: 90–150 minutes depending on complexity
Setting: Advanced vitreoretinal surgery center
Recovery & After-Care
After-Care Guidelines
- Maintain head positioning if gas tamponade is used
- Avoid heavy lifting, bending, or eye rubbing
- Follow all prescribed eye drops
- Attend all scheduled postoperative visits
Recovery Timeline
- Immediate: Blurred vision from gas or surgery
- 1–2 Weeks: Reduced inflammation and initial visual improvement
- 2–6 Weeks: Blood absorption or displacement confirmed on OCT
- 1–3 Months: Maximum visual improvement and retinal stabilization
Results & Longevity
Expected Results
- Successful displacement or removal of submacular blood
- Protection of photoreceptors from further damage
- Improved central visual function
- Reduced risk of macular scarring or permanent vision loss
Longevity
- Permanent anatomical repair at the macula
- Lifelong OCT monitoring recommended for AMD or PCV patients
- Combined surgical and pharmacologic management ensures durable outcomes
Why Korea Is a Top Destination
- Experienced vitreoretinal surgeons specialized in submacular hemorrhage
- Microincision vitrectomy for minimal trauma
- Intraoperative OCT-guided precision
- Advanced gas tamponade and tPA techniques
- Integration with anti-VEGF therapy for optimal outcomes
- High success rates with rapid outpatient or short-stay protocols
Unique Korean Innovations
- AI-assisted surgical mapping for submacular hemorrhage
- Ultra-fine microcannulas for tPA delivery
- Pneumatic displacement techniques optimized with OCT guidance
- Combined vitrectomy and pharmacologic therapy for AMD or PCV
- Personalized postoperative positioning protocols
Cost Range (Indicative Estimate)
| Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Standard Submacular Hemorrhage Removal | ₩5,000,000 – ₩8,500,000 | ~$3,900 – $6,600 | 25G/27G vitrectomy + subretinal tPA + OCT follow-up |
| Removal + Gas Tamponade | ₩6,500,000 – ₩10,500,000 | ~$5,100 – $8,100 | Vitrectomy + tPA + gas tamponade + OCT monitoring |
| Combined Procedure (Surgery + Anti-VEGF) | ₩8,000,000 – ₩12,500,000 | ~$6,200 – $9,600 | Vitrectomy + tPA + gas tamponade + anti-VEGF therapy + follow-up |
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul)
- Dream Eye Center (Seoul)
- BGN Eye Clinic (Seoul & Busan)
- Kim’s Eye Hospital (Seoul)
- Seoul National University Hospital – Retina Center
- NUNE Eye Hospital (Daegu)
- Glory Seoul Eye Clinic
- Gangnam Severance Hospital – Ophthalmology
